Vivimed N

Acetaminophen

Method of action: Analgesic, Anti-Inflammatory, Antipyretic, Pain Reliever

Treatment option: Arthralgia, Period Pain, Backache, Pain, Sore Throat, Earache, Headache, Influenza, Toothache, Fever

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vivimed N

Property	Description
Active ingredient	Acetaminophen (Paracetamol)
Form	Oral tablet
Pharmacological class	Analgesic, Antipyretic
General use	Symptomatic relief of pain and fever
Origin	Synthetic

Vivimed N is an established, non-narcotic pharmaceutical preparation defined as a simple analgesic and antipyretic. Its primary therapeutic action involves reducing both pain and fever.

This Over-the-Counter (OTC) oral medicine is a monopreparation, meaning its therapeutic effect stems solely from its single active substance, rather than a combination of ingredients. Acetaminophen is a widely used and effective agent for these purposes, providing a reliable therapeutic profile for common discomforts. The drug is clinically recognized for its role in easing discomfort and lowering elevated temperatures.

The sole active ingredient in Vivimed N is Acetaminophen (Paracetamol), a synthetic compound formulated as an oral tablet. This substance is structurally defined by its active component combined with inert excipients necessary for the tablet's stability and dissolution. The general benefit of this specific composition is its predictable ability to effectively alleviate diverse types of pain and consistently reduce fever. This action is achieved by influencing central pain pathways and the body's temperature regulation center, offering a defined solution for generalized symptomatic relief.

Regulatory References

What side effects are possible with Vivimed N?

Possible side effects and safety information

The official safety profile for Vivimed N, which contains Acetaminophen (Paracetamol), is structured to primarily communicate the risk of serious adverse reactions rather than common, minor effects. Most clinically significant adverse reactions are classified in official regulatory documents as Rare or Very Rare events.

Adverse Reaction Categories and Systems

Adverse reactions are officially documented across several System-Organ Classes, most notably the Hepato-biliary disorders (liver), Skin and subcutaneous tissue disorders, Blood and lymphatic system disorders, and Immune system disorders.

Serious Adverse Reactions

The most significant documented risk is Acute Liver Failure or Severe Liver Damage, which is strongly associated with exceeding the maximum recommended daily dose. Other serious, rare adverse reactions include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as certain blood dyscrasias, including Agranulocytosis and Thrombocytopenia.

Safety Restrictions and Contextual Patterns

The official safety documents identify specific safety restrictions. Vivimed N is generally contraindicated in individuals with known severe hypersensitivity to the active substance. Furthermore, the risk of hepatotoxicity is heightened for patients with pre-existing severe hepatic impairment or those who are chronic alcohol users, requiring caution in these populations. The safety profile also outlines a difference between acute liver damage, linked to single-dose overdose, and other effects like Nephropathy, which are associated with prolonged, high-dose exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Vivimed N (Acetaminophen/Paracetamol) emphasizes the risk of serious, delayed organ damage following an overdose.

Documented Overdose Manifestations

Initial overdose symptoms are often non-specific, primarily including pallor, nausea, vomiting, anorexia, and abdominal pain. Crucially, these early clinical signs may be minimal and do not reflect the severity of the intoxication. Clinical or laboratory evidence of severe liver damage, such as jaundice, may not become apparent until 12 to 48 hours after ingestion. Severe consequences documented include hepatic cell necrosis, acute liver failure, metabolic acidosis, and potentially death.

Mandated Emergency Actions

Immediate medical advice must be sought in the event of an overdose. This action is required even if the patient feels well or if symptoms are absent, due to the high risk of delayed, serious liver damage. Patients must be referred to a hospital urgently for immediate medical attention and monitoring.

Supportive Procedures

An overdose necessitates the measurement of plasma paracetamol concentration at 4 hours or later. The specific antidote, N-acetylcysteine (NAC), is documented in official labeling, with its maximum protective effect constrained to administration within the first 8 hours post-ingestion. Activated charcoal may be considered if ingestion occurred within one hour. Risk factors, including chronic alcoholism or severe malnutrition, are officially noted to increase the hazard of toxicity at lower ingested amounts.

Therapeutic Uses of Vivimed N

Vivimed N (Acetaminophen/Paracetamol) is classified as a simple analgesic and antipyretic used to provide symptomatic support by addressing two primary domains of discomfort that often cluster together in acute illnesses.

The medication is used to help ease mild to moderate pain and assist in the management of fever.

Easing Mild to Moderate Pain

This medicine is commonly used for managing symptoms related to physical discomfort across various symptomatic manifestations, including tension headaches, general muscle aches (myalgia), minor joint pain, backache, and dental pain. Applied in scenarios where additional management of discomfort is required, Vivimed N generally assists with maintaining functional stability during symptomatic periods by helping reduce the overall burden of episodic discomfort associated with acute changes.

“It is commonly used when symptoms intensify and supportive relief is needed.”

Managing Fever and Systemic Symptoms

Vivimed N is considered relevant in contexts involving heightened systemic burden by helping reduce pyrexia (fever), which is a symptom related to systemic imbalance. This action plays a role in managing conditions like the common cold and influenza, where fever often clusters with widespread body aches. By addressing the fever, the medication offers symptomatic support that contributes to improved comfort during periods of heightened symptoms, supporting the patient during difficult episodes by easing distress.

Quick Fact: Relevant for Headache and Fever Symptoms

Regulatory References

Acetaminophen

Eligibility and Restrictions for Use

Who Can and Cannot Use Vivimed N?

The eligibility for using Vivimed N (Acetaminophen/Paracetamol) is defined by official government regulatory standards, which specify both approved populations and absolute exclusions.

Contraindicated Populations (Must Not Use)

Official labeling strictly prohibits the use of this medicine in the following groups:

Hypersensitivity: Patients with a documented allergy or known hypersensitivity to acetaminophen or any component of the tablet.
Severe Liver Disease: Individuals diagnosed with severe hepatocellular insufficiency or active, severe liver disease.
Pediatric Age Limits: Children below the minimum age specified for the standard tablet formulation (often under 12 years).

Approved and Restricted Populations

Population Group	Regulatory Eligibility Status
Adults and Adolescents (ge 12 years)	Approved as the standard patient population for use.
Severe Renal Impairment	Restricted Use; requires an official extension of the dose interval for safe use.
Chronic Alcoholism/Malnutrition	Restricted Use; requires medical caution due to increased risk of hepatotoxicity.
Pregnancy and Breastfeeding	Conditional Use; permitted only at the lowest effective dose for the shortest duration, requiring medical consultation.

This structure ensures the medicine is used only by populations where the risk profile is officially deemed acceptable or manageable through specific medical caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interactions for Vivimed N (Acetaminophen/Paracetamol), strictly based on governmental regulatory information.

Contraindicated Combinations

Vivimed N must not be used with any other prescription or nonprescription drug containing acetaminophen. This prohibition is due to the significant risk of severe liver damage (hepatotoxicity) from exceeding the maximum daily dose.

Documented Drug-Drug Interactions

Interacting Substance(s)	Official Documented Effect(s)
Probenecid (Anti-gout)	Reduces Acetaminophen clearance (approximately two-fold).
Vitamin K Antagonists (e.g., Warfarin)	Prolonged regular use may enhance the anticoagulant effect, increasing the risk of bleeding.
Hepatic Enzyme Inducers (e.g., Phenytoin)	May increase the severity of Acetaminophen overdose by promoting toxic metabolite formation.
Metoclopramide or Domperidone	Accelerate the absorption rate of Acetaminophen.
Cholestyramine	Reduces the absorption of Acetaminophen.

Timing and Lifestyle Considerations

When co-administering Cholestyramine, Acetaminophen should be taken at least 1 hour before or 4 hours after the sequestrant to mitigate reduced absorption. A specific caution exists regarding alcohol: severe liver damage risk is officially documented if the patient consumes three or more alcoholic drinks every day while using acetaminophen. Risks are heightened in patients with non-cirrhotic alcoholic liver disease.

Mechanism of Action

Vivimed N contains paracetamol, which exerts its effects primarily within the central nervous system (CNS) due to its enhanced penetration of the blood-brain barrier compared to peripheral tissues. Its main action is a functional inhibitor of cyclooxygenase (COX) activity, predominantly involving centrally expressed COX isoforms, possibly the COX-2 enzyme or a splice variant. The molecular interaction leads to a marked reduction in the synthesis of prostaglandins (PGs), specifically PGE2, within the hypothalamus and spinal cord. The intracellular consequence is a modulation of the hypothalamic thermoregulatory set-point and a diminished activation of central nociceptive pathways. Downstream, this central PG synthesis suppression results in an increase in cutaneous blood flow and heat dissipation at the system level. The drug may also act through a metabolite, AM404, which is hypothesized to modulate the endocannabinoid system via agonism of the transient receptor potential vanilloid-1 (TRPV1) receptor and inhibit cellular reuptake of endogenous cannabinoids, further contributing to central signal modification.

Dosage and Administration Information

Administration Guidelines for Vivimed N (Acetaminophen)

Vivimed N is an immediate-release oral tablet, and its correct usage is governed by precise parameters to ensure proper administration.

Entity	Administration Instruction
Route of Administration	The approved route for this tablet form is oral (swallowing).
Standard Dosing Regimen	For adults and adolescents weighing 50 kg or more, the standard single dose is 650 mg to 1000 mg. Dosing is repeated every 4 to 6 hours as needed for symptoms.
Maximum Daily Dose	The maximum allowable intake from all acetaminophen-containing products must not exceed 4000 mg (4 grams) in any 24-hour period.
Timing and Intake	The tablet may be taken with or without food and should be swallowed whole with liquid.
Population Adjustments	Patients with hepatic or severe renal impairment may require reduced maximum daily doses (e.g., 2000 mg or less) and extended dosing intervals.
Duration Constraint	For self-medication, use is generally restricted to 10 days or less for pain and 3 days or less for fever.

The use protocol is predicated on adherence to dose frequency and maximum limits. The key procedural constraint is the minimum interval of 4 hours between doses, coupled with the requirement to track all sources of the active ingredient to ensure the total 4000 mg threshold is never surpassed. This structured, time-dependent protocol defines the method for using the medicine.

Recent Clinical Evidence

Metformin: Recent Clinical Evidence

Metformin is an oral medication that is used for the indication of managing blood glucose levels in adults and children with type 2 diabetes mellitus. It is a treatment option often considered in initial therapy, which frequently includes diet and exercise adjustments. The medication is classified as a biguanide.

Clinical trials and systematic reviews indicate that Metformin use has been associated with observed reductions in A1C levels in people with type 2 diabetes. Furthermore, published studies include reports suggesting a possible association with cardiovascular markers, although this remains an area of active and ongoing research.

Research has also explored the use of Metformin in the context of Polycystic Ovary Syndrome (PCOS). Studies specifically examined its effects on symptoms associated with the condition. Research on Metformin in PCOS includes observations related to effects on insulin resistance and irregular menstrual cycles in some patients.

Some observational data and studies suggest that Metformin use may be associated with weight neutrality or modest weight loss, which is a finding that has been noted in the context of some other medications for diabetes. It is important to note that the regulatory indication for Metformin is not primary weight-loss treatment.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Vivimed N (FAQ)

Q: What is Vivimed N and how is it used?

Vivimed N (Nifedipine) belongs to a group of medications known as calcium channel blockers. These are primarily prescribed to help manage high blood pressure (hypertension) and to help control chest pain associated with certain heart conditions (angina).

Q: How does Vivimed N work in the body?

As a calcium channel blocker, Vivimed N is designed to work by inhibiting the movement of calcium into the cells of the heart and blood vessel walls. This action is associated with relaxing the smooth muscle in blood vessels, which in turn may help to dilate them. This vascular effect may contribute to the lowering of blood pressure and the reduction of strain on the heart, which is important in managing angina symptoms.

Q: Is Vivimed N effective for treating high blood pressure?

Clinical trials have consistently shown that Vivimed N is associated with a significant reduction in blood pressure levels in individuals with hypertension. These findings support its use as an established treatment option for managing this condition. Individual results may vary.

Q: What are the common side effects of Vivimed N?

Clinical data indicates that Vivimed N is generally well tolerated by most patients. Common and expected side effects, which were frequently observed in clinical studies, may include headache, flushing (a feeling of warmth or redness), swelling of the ankles or feet, and dizziness. Patients should discuss any side effects with a healthcare professional.

Q: Can Vivimed N be taken with other heart medications?

Combining Vivimed N with other medications, particularly those that also affect blood pressure or heart rate, may require careful monitoring by a healthcare professional. These combinations can potentially alter the intended effects of one or both drugs. A physician must review all current medications before starting Vivimed N, and any changes should only be made under their guidance.

How should Vivimed N be stored and disposed of?

Storage Requirements

Vivimed N must be stored at controlled room temperature and maintained in a dry place. The medication must be kept in its original container or packaging and the container should be kept tightly closed to protect the tablets from moisture and light. It is a mandatory requirement to store the product out of the sight and reach of children to prevent accidental ingestion. Do not use the medicine past the expiration date printed on the packaging.

Disposal Instructions

Official regulatory guidelines advise that the preferred method for discarding unused or expired Vivimed N is through a community drug take-back program or mail-back option. Disposal into the wastewater system (toilet or sink) is prohibited. If a take-back program is unavailable, follow household disposal procedures by mixing the medicine with an undesirable substance before placing it in a sealed container for the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Germany

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z